← All providers

Rugiet Health vs Foundayo

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Rugiet Health vs Foundayo: Overview

Choosing between Rugiet Health and Foundayo for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.

Rugiet Health offers both semaglutide and tirzepatide at $87/month with a rating of 7.6/10. Foundayo offers orforglipron at $149/month with a 9.2/10 rating.

The price difference of $62/month is significant - Rugiet Health is the more budget-friendly option, while Foundayo positions itself as a premium service.

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

Visit CoreAge Rx →Read full review

At a glance

Price Difference

$62/mo

Rating Difference

1.6

Winner

Foundayo

Best For

Quality

Rugiet Health

View full Rugiet Health review →

Rating

7.6/10

Monthly Price

$87Cheaper

Medications

sildenafiltadalafilapomorphineparoxetineenclomiphene

Pros

✓The compounded disclosure is exactly right and sits on the product page itself: 'Ready is a compounded drug product and requires a prescription. Compounded drugs are not approved by FDA and do not undergo review or verification by FDA for safety, effectiveness, or quality.' This is the clearest regulatory statement we have seen from any compounded-medication brand
✓A named nine-person Medical Advisory Board, mostly board-certified urologists, plus a named Chief Medical Officer - real, checkable clinical governance rather than an anonymous 'medical team'
✓Roughly 2,000 Trustpilot reviews at 4.3, with 100% of negative reviews answered, typically inside 24 hours
✓It publishes its own pricing article stating Ready starts at $7.29 per dose, and explains that the exact figure depends on the concentration prescribed (checked July 28, 2026)
✓Efficacy claims carry disclosed methodology - the onset figure is footnoted to a survey of 101 customers and another to 114 active patients in May 2025. The samples are small, but the sourcing is stated rather than hidden
✓Enclomiphene is marked 'Labs Required', so at least one product line has a genuine bloodwork gate rather than symptom-only prescribing
✓It states plainly that most insurance does not cover compounded medications, instead of implying coverage might apply
✓HSA/FSA eligible, free doctor consultation and shipping included, and a mobile app is available
✓Published phone support Monday to Friday plus Saturday hours, which is broader than most competitors

Cons

✗Ready stacks two PDE5 inhibitors - sildenafil and tadalafil - in a single dose, alongside apomorphine. No FDA-approved product combines two PDE5 inhibitors, and doubling the same mechanism compounds the blood-pressure-lowering effect without established additional benefit
✗Apomorphine is a dopamine agonist whose US approval is for 'off' episodes in advanced Parkinson's disease. Using it for arousal is off-label, and it independently causes nausea, low blood pressure and sudden sleep onset - risks that stack with the two PDE5 inhibitors
✗No price appears anywhere on the product pages, the treatment catalogue or the intake funnel. The only published figure sits in a blog post, so a shopper following the normal path has to create an account before learning what anything costs
✗Pricing is per dose rather than a flat monthly fee, so the monthly figure shown here reflects 12 doses at the $7.29 starting rate for comparison against similarly sold products. Your real cost depends on the concentration prescribed and how often you use it
✗'Up to 3x the power of generics' and 'delivers stronger, more reliable results than sildenafil or tadalafil alone' are comparative efficacy claims with no trial cited
✗The headline results - 85% feeling more confident, 80% preferring Rugiet - come from internal surveys of around 101 to 114 of the company's own customers, not controlled studies
✗Go Long combines paroxetine, an SSRI, with ED medication for premature ejaculation. SSRIs are used off-label for this, and paroxetine carries its own discontinuation and sexual side-effect profile
✗The '500k+ men choose Rugiet' figure is the company's own with no independent corroboration
✗Anyone taking nitrates or riociguat must not use these products, and the apomorphine component adds a serious interaction with 5-HT3 anti-emetics such as ondansetron

Choose Rugiet Health

Foundayo

View full Foundayo review →

Rating

9.2/10Better

Monthly Price

$149

Medications

orforglipron

Pros

✓The first and only FDA-approved GLP-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 April 2026
✓In the ATTAIN-1 trial, participants on the highest dose who stayed on treatment lost an average of 27.3 pounds (12.4% of body weight) against 2.2 pounds (0.9%) on placebo
✓Counting everyone randomised regardless of whether they finished, the average was still 25 pounds (11.1%) versus 5.3 pounds (2.1%) on placebo - Lilly published both numbers rather than only the flattering one
✓A once-daily tablet, so there is no injection, no needle disposal and no refrigeration to organise
✓Self-pay pricing is published up front at $149 per month for the lowest dose through LillyDirect, with free home delivery
✓Eligible people with commercial insurance may pay as little as $25 per month with the Foundayo savings card
✓Eligible Medicare Part D patients may be able to get it for $50 per month from as early as 1 July 2026 - a rarity in this category
✓Lilly reported reductions in waist circumference, non-HDL cholesterol, triglycerides and systolic blood pressure across all doses
✓It is a small-molecule (non-peptide) GLP-1, which is why it can be manufactured as a pill rather than an injection

Cons

✗Weight loss is meaningfully lower than the best injectables. 12.4% at the top dose sits below tirzepatide territory, so if maximum weight loss is the goal an injection still wins
✗It carries the class boxed warning: it may cause thyroid tumours including thyroid cancer, and must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
✗Should not be used alongside another GLP-1 receptor agonist
✗Common side effects include nausea, constipation, diarrhoea, vomiting, indigestion, abdominal pain, headache, fatigue, heartburn, gas and hair loss
✗Serious risks in the label include pancreatitis, dehydration leading to kidney problems, gallbladder problems, severe allergic reactions and aspiration risk under anaesthesia
✗Safety and effectiveness in children have not been established
✗$149 is the price of the lowest dose only - higher doses cost more, and the $25 and $50 figures depend on insurance eligibility rather than being available to everyone
✗Very new to market, so there is no long-term real-world safety and adherence record yet

Choose Foundayo

Feature-by-feature comparison

Feature	Rugiet Health	Foundayo
Monthly Price	$87	$149
Rating	7.6/10	9.2/10
Medications	sildenafil, tadalafil, apomorphine, paroxetine, enclomiphene	orforglipron
Insurance Accepted	No	Yes
Support Hours	Monday to Friday 8:30am-5:30pm CT, Saturday 11am-4pm CT	Not published
Live Chat	No	No
Free Shipping	Yes	Yes
Shipping Speed	Discreet delivery; free shipping included in subscription plans	Free home delivery via LillyDirect; shipping began 6 April 2026
Mobile App	Available	No
Dedicated Coach	Not included	Not included
Follow-up Frequency	Ongoing provider access through the platform and app; cadence not published	As directed by your prescriber
Money-back Guarantee	None published	None published; this is a prescription medicine, not a subscription service
Cancellation Policy	Subscription based; buy 2 months of Ready and get the 3rd free promotion running at time of review	Prescription-based - stopping treatment is a decision for you and your prescriber

Which should you choose?

Choose Rugiet Health if you:

→Want to save $62/month with a more affordable option
→Want more medication options to choose from
→Value: the compounded disclosure is exactly right and sits on the product page itself: 'ready is a compounded drug product and requires a prescription. compounded drugs are not approved by fda and do not undergo review or verification by fda for safety, effectiveness, or quality.' this is the clearest regulatory statement we have seen from any compounded-medication brand

Get started with Rugiet Health

Choose Foundayo if you:

→Prefer a higher-rated service (9.2/10 vs 7.6/10)
→Need insurance coverage for your treatment
→Value: the first and only fda-approved glp-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 april 2026

Get started with Foundayo

Website previews

Rugiet Health

Rugiet Health website

Foundayo

Foundayo website

Our recommendation

Foundayo comes out ahead with a higher rating of 9.2/10.

Get started with Foundayo

Related comparisons

Rugiet Health vs CoreAge Rx

Rugiet Health vs Zepbound

Rugiet Health vs Mounjaro

Rugiet Health vs Wegovy Pill

Rugiet Health vs Wegovy

Rugiet Health vs NovoCare Pharmacy

Rugiet Health vs Ozempic

Rugiet Health vs Form Health

Rugiet Health vs Henry Meds

Rugiet Health vs Sesame Care

Rugiet Health vs FuturHealth

Rugiet Health vs Circle Medical

Rugiet Health vs Ro

Rugiet Health vs Midi Health

Rugiet Health vs Noom Med

Rugiet Health vs Precision Telemed

Rugiet Health vs Hims

Rugiet Health vs Calibrate

Rugiet Health vs PlushCare

Rugiet Health vs LifeMD

Compare other providers

Compare GLP-1 Brands

First Brand

vs

Second Brand